Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00148954 · ClinicalTrials.gov registry record · Phase 4
RIGHT: Rhythm ID Going Head-to-Head Trial
A Phase 4 study of Tachycardia, sponsored by Boston Scientific Corporation.
- Completed
- Registry status
- Phase 4
- Development phase
- 1,962
- Enrollment target
- 1
- Study location
NCT00148954 is a Phase 4 study of Tachycardia that has completed, run by Boston Scientific Corporation. The registered enrollment target is 1,962 participants, above the 653-participant average among 8 other Tachycardia trials with a reported enrollment target (200% higher). The trial reports 1 study location across 1 state.
The verdict
NCT00148954, a Phase 4 study of Tachycardia, has completed, sponsored by Boston Scientific Corporation.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 1,962 participants
- Enrollment target
- 1
- Study location
Study Summary
RIGHT is a randomized, prospective, two-arm study that will assess the differential efficacy of VITALITY 2 implantable cardioverter defibrillators (ICDs) using Rhythm ID™ versus selected Medtronic ICDs.
Conditions Studied
Interventions
- DEVICE VITALITY 2 Implantable Cardioverter Defibrillator
- DEVICE Medtronic Implantable Cardioverter Defibrillator
Study Locations (1)
South Carolina
- Medical University of South Carolina - Charleston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,962 participants |
| Start Date | 2005-07 |
| Est. Completion | 2010-07 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00148954
The ClinicalTrials.gov registry entry for NCT00148954 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 1,962 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 653-participant average among 8 other Tachycardia trials with a reported enrollment target (200% higher). The listed sponsor is Boston Scientific Corporation, which has 280 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Tachycardia appearing as the primary indexed condition, and to 2 interventions - of which VITALITY 2 Implantable Cardioverter Defibrillator is the first listed.
NCT00148954 reports 1 study location spanning 1 distinct geographic area - top geographies include South Carolina.
Frequently Asked Questions
What is clinical trial NCT00148954 about?
NCT00148954 is a clinical study titled "RIGHT: Rhythm ID Going Head-to-Head Trial". RIGHT is a randomized, prospective, two-arm study that will assess the differential efficacy of VITALITY 2 implantable cardioverter defibrillators (ICDs) using Rhythm ID™ versus selected Medtronic ICDs.
What is the current status of trial NCT00148954?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 1,962 participants. The study started on 2005-07. Estimated completion is 2010-07.
What conditions does trial NCT00148954 study?
This clinical trial studies the following conditions: Tachycardia.
What interventions are being tested in trial NCT00148954?
The interventions under investigation include: VITALITY 2 Implantable Cardioverter Defibrillator (DEVICE), Medtronic Implantable Cardioverter Defibrillator (DEVICE).
Who is sponsoring clinical trial NCT00148954?
This trial is sponsored by Boston Scientific Corporation, which has 280 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00148954 being conducted?
This trial has 1 study location across South Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Tachycardia
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Optimal Anti-tachycardia Therapy in Implantable Cardioverter-defibrillator (ICD) Patients Without Pacing Indications
COMPLETED · Phase 4
-
TriVerity™ for Improved Management of Emergency Department (ED) Patients With Suspected Infections
RECRUITING · NA
-
Treatment of Orthostatic Intolerance
ACTIVE NOT RECRUITING · Phase 1
-
Detection and Classification of Cardiac Rhythm and Atrial Fibrillation Using a Finger-worn Ring
ACTIVE NOT RECRUITING
-
Enlighten Study: The EV-ICD Post Approval Registry
ACTIVE NOT RECRUITING
-
Pathophysiology of Orthostatic Intolerance
ACTIVE NOT RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.